Phase II study of cetuximab in combination with FOLFIRI in patients with untreated advanced gastric or gastroesophageal junction adenocarcinoma (FOLCETUX study). (Q43604675)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase II study of cetuximab in combination with FOLFIRI in patients with untreated advanced gastric or gastroesophageal junction adenocarcinoma (FOLCETUX study). |
scientific article |
Statements
1 reference
Phase II study of cetuximab in combination with FOLFIRI in patients with untreated advanced gastric or gastroesophageal junction adenocarcinoma (FOLCETUX study). (English)
1 reference
1 reference
1 reference
C Pinto
1 reference
F Di Fabio
1 reference
S Siena
1 reference
F L Rojas Llimpe
1 reference
V Mutri
1 reference
L Giannetta
1 reference
S Giaquinta
1 reference
C Funaioli
1 reference
C Longobardi
1 reference
E Piana
1 reference
A A Martoni
1 reference
12 December 2006
1 reference
1 reference
Identifiers
1 reference